SR0105 104TH GENERAL ASSEMBLY

SR0105 LRB104 10584 LAW 20660 r

SENATE RESOLUTION

WHEREAS, Serious mental illnesses like bipolar disorder, major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise; and

WHEREAS, While prolonged antipsychotic use may be essential for the treatment of certain conditions, it is associated with tardive dyskinesia (TD), a condition marked by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, or extremities; and

WHEREAS, People at higher risk of TD include those older than 55 years, people who are Black, women, individuals with mood or substance use disorders, intellectual disabilities, or central nervous system injuries, and those with high cumulative antipsychotic exposure; and

WHEREAS, Approximately 60% of the estimated 800,000 U.S. adults living with TD remain undiagnosed, and even mild TD symptoms can be stigmatizing and impair physical, social, and emotional well-being, underscoring the urgency of early screening, detection, and intervention; and

WHEREAS, The American Psychiatric Association recommends routine TD screening in their clinical guidelines for antipsychotic treatment, and individuals treated with antipsychotics or experiencing abnormal movements should consult their health care providers to assess TD risk, receive TD screenings, and determine appropriate treatment together; and

WHEREAS, FDA-approved treatments for TD can provide options for symptom management and improved quality of life for many individuals living with TD; and

WHEREAS, The General Assembly can encourage TD screening education and awareness for health care providers, patients, and care partners to help ensure patients prescribed antipsychotics receive care and support that aligns with clinical best practices, including regular TD screenings; therefore, be it

RESOLVED, BY THE SENATE OF THE ONE HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that we declare May 4 through May 10, 2025 as Tardive Dyskinesia Awareness Week (TDAW) in the State of Illinois; and be it further

RESOLVED, That we support TDAW in recognition of the importance of early detection and intervention to improve outcomes for people living with mental health conditions and prescribed antipsychotics, and we support efforts to raise awareness about the causes and symptoms of tardive dyskinesia (TD) and the importance of routine TD screening.